Dr Robert Hibberd Saxton, MD | |
208 Chama Dr, Hewitt, TX 76643-3368 | |
(254) 772-2372 | |
(254) 870-1991 |
Full Name | Dr Robert Hibberd Saxton |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 208 Chama Dr, Hewitt, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740435130 | NPI | - | NPPES |
126283406 | Medicaid | TX | |
D1498 | Other | TX | TEXAS LICENSE |
P01032224 | Other | TX | PALMETTO GBA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | D1489 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Hibberd Saxton, MD Po Box 21265, Waco, TX 76702-1265 Ph: (254) 772-2372 | Dr Robert Hibberd Saxton, MD 208 Chama Dr, Hewitt, TX 76643-3368 Ph: (254) 772-2372 |
News Archive
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
Democrats loathe Medicare Advantage because it sanctions the private choices that might eventually liberate the U.S. health market from government price controls. They also wanted to raid Advantage to finance their new subsidies (6/11).
A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance.
The protein CARD8 regulates several inflammatory proteins in people with atherosclerosis. This is shown in a new study by örebro researchers published in the scientific journal Scientific Reports.
Sequencing the human genome was just the first step. The next challenge is of the kind that makes history: to decode the genome, and understand how the information needed to construct a human being can be packaged into a single molecule.
› Verified 6 days ago